Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Nivedita Gupta and Pragya Yadav.
Nivedita Gupta
Connection Strength
2.829
Pragya Yadav
  1. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.243
  2. An Epidemiological Analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India. Viruses. 2021 05 17; 13(5).
    View in: PubMed
    Score: 0.236
  3. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India. Travel Med Infect Dis. 2021 May-Jun; 41:102023.
    View in: PubMed
    Score: 0.234
  4. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun. 2021 03 02; 12(1):1386.
    View in: PubMed
    Score: 0.233
  5. Authors' response. Indian J Med Res. 2020 05; 151(5):496.
    View in: PubMed
    Score: 0.220
  6. Laboratory preparedness for SARS-CoV-2 testing in India: Harnessing a network of Virus Research & Diagnostic Laboratories. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):216-225.
    View in: PubMed
    Score: 0.216
  7. Biorisk assessment for infrastructure & biosafety requirements for the laboratories providing coronavirus SARS-CoV-2/(COVID-19) diagnosis. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):172-176.
    View in: PubMed
    Score: 0.216
  8. Detection of coronaviruses in Pteropus & Rousettus species of bats from different States of India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):226-235.
    View in: PubMed
    Score: 0.216
  9. Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.061
  10. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med. 2021 10 11; 28(7).
    View in: PubMed
    Score: 0.061
  11. SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India. Microorganisms. 2021 Jul 20; 9(7).
    View in: PubMed
    Score: 0.060
  12. Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2. J Travel Med. 2021 Jun 01; 28(4).
    View in: PubMed
    Score: 0.059
  13. Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluation. iScience. 2021 Apr 23; 24(4):102298.
    View in: PubMed
    Score: 0.058
  14. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial. Lancet Infect Dis. 2021 07; 21(7):950-961.
    View in: PubMed
    Score: 0.058
  15. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021 05; 21(5):637-646.
    View in: PubMed
    Score: 0.058
  16. Immunogenicity and protective efficacy of BBV152, whole virion inactivated SARS- CoV-2 vaccine candidates in the Syrian hamster model. iScience. 2021 Feb 19; 24(2):102054.
    View in: PubMed
    Score: 0.058
  17. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):93-114.
    View in: PubMed
    Score: 0.058
  18. Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):144-150.
    View in: PubMed
    Score: 0.058
  19. Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019. Indian J Med Res. 2020 Nov 04.
    View in: PubMed
    Score: 0.057
  20. Development of indigenous IgG ELISA for the detection of anti-SARS-CoV-2 IgG. Indian J Med Res. 2020 May; 151(5):444-449.
    View in: PubMed
    Score: 0.055
  21. Evaluation of the susceptibility of mice & hamsters to SARS-CoV-2 infection. Indian J Med Res. 2020 May; 151(5):479-482.
    View in: PubMed
    Score: 0.055
  22. First isolation of SARS-CoV-2 from clinical samples in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):244-250.
    View in: PubMed
    Score: 0.054
  23. Genomic analysis of SARS-CoV-2 strains among Indians returning from Italy, Iran & China, & Italian tourists in India. Indian J Med Res. 2020 Feb & Mar; 151(2 & 3):255-260.
    View in: PubMed
    Score: 0.054
  24. Canine Distemper Virus in Asiatic Lions of Gujarat State, India. Emerg Infect Dis. 2019 11; 25(11):2128-2130.
    View in: PubMed
    Score: 0.053
  25. Spatial Association Between a Nipah Virus Outbreak in India and Nipah Virus Infection in Pteropus Bats. Clin Infect Dis. 2019 07 02; 69(2):378-379.
    View in: PubMed
    Score: 0.052
  26. First laboratory confirmation on the existence of Zika virus disease in India. J Infect. 2018 03; 76(3):314-317.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.